Cyclin D-CDK4 kinase destabilizes PD-L1 via culliculin 3-SPOP to control tumor surveillance: proteasome or ubiquitin E3 ligase inhibitors incremented PD-L1 expression [75]. The gene discussed is CD274; the disease is neoplasm.